Reddy’s Exclusivity End Allows Teva, Natco To Match Full US Revlimid Suite

Controversial BMS Brand, Generics Challenged In Ongoing US Antitrust Suit

 
• By Dean Rudge

Teva has moved fast to match Dr Reddy’s Laboratories’ complete six-strength offering of generic Revlimid (lenalidomide) products in the US.

Open Book Of prostate multiple myeloma, Conceptual Image - Image
• Source: Shutterstock

More from Products

More from Generics Bulletin